Ambu's Q3 ended better than expected
After a downgrade earlier in the year, pessimism had grown regarding Ambu's third quarter, though it turned out to go slightly above expectations. The launch of one of the firm's new products is postponed, however.
by ELIZABETH MØNSTED JOHANSEN, translated by jonas sahl jørgensen
The third-quarter financials of Danish medical technology firm Ambu ended up slightly better than expected earlier this year after the company presented preliminary figures in connection with a downgrade.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu brings plans for Mexico factory forward
For subscribers
Ambu downgrades due to covid-19 and logistical challenges
For subscribers
.jpg&w=384&q=75)
